Top 10 Medical Devices Market

TABLE OF CONTENTS

EXECUTIVE SUMMARY 
  OBJECTIVE
  MARKET SCENARIO

1 INTRODUCTION
  1.1 KEY TAKE-AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY

2 SUMMARY

3 MARKET OVERVIEW
  3.1 INTRODUCTION
  3.2 DEFINITION OF TOP 10 MEDICAL DEVICES MARKET
  3.3 DRIVERS
      3.3.1 AGING POPULATION IS A MAJOR GROWTH FACTOR
      3.3.2 ACCEPTANCE OF NEWER TECHNOLOGIES BY THE PHYSICIANS
      3.3.3 OUTSOURCING OF MEDICAL EQUIPMENT
  3.4 RESTRAINTS
      3.4.1 U.S. HEALTHCARE REFORM IMPACTING  THE MEDICAL DEVICE COMPANIES
            3.4.1.1 Excise tax
            3.4.1.2 Reduction in hospital orders
  3.5 OPPORTUNITIES
      3.5.1 RAPID GROWTH IN EMERGING MARKETS
      3.5.2 SECTORAL GROWTH IS EXPECTED POST IMPLEMENTATION OF REFORMS
  3.6 MEDICAL DEVICES MARKET SHARE
  3.7 MARKET DOMINANCE OF U.S. MANUFACTURERS
  3.8 HIGHER VISIBILITY OF CORE MEDICAL DEVICES COMPANIES
  3.9 CARDIOVASCULAR & ORTHOPEDICS DEVICES LEADING THE MARKET
  3.10 PATENT ANALYSIS
      3.10.1 DEVICE MANUFACTURERS FOCUSING ON RESPIRATORY DEVICES & PATIENT MONITORING
      3.10.2 KEY INDUSTRIAL PARTICIPANTS FOCUSING ON IMAGING AND DIALYSIS

4 DIAGNOSTIC IMAGING
  4.1 INTRODUCTION
  4.2 DRIVERS
      4.2.1 NEW TECHNOLOGIES FOR DIAGNOSTIC IMAGING ENHANCE THE MARKET GROWTH
      4.2.2 EXPANDING APPLICATIONS FOR DIAGNOSTIC IMAGING
  4.3 BURNING ISSUES
      4.3.1 FDA INTERVENTION IN MEDICAL IMAGING TESTS
  4.4 MARKET SHARE
  4.5 ULTRASOUND
      4.5.1 DRIVERS
            4.5.1.1 Demand from emerging markets drives the ultrasound devices growth
            4.5.1.2 Increasing use of ultrasound equipment by  non-radiologists & for emergency medicine
      4.5.2 APPLICATION AREAS FOR ULTRASOUND IMAGING
      4.5.3 MARKET SHARE
  4.6 X-RAY
      4.6.1 DRIVERS
            4.6.1.1 Digital radiography boosts the overall X-ray equipment market
            4.6.1.2 Mammography diagnosis supports the X-ray equipment growth
  4.7 NUCLEAR IMAGING
  4.8 MRI
  4.9 COMPUTED TOMOGRAPHY (CT)

5 CARDIOVASCULAR DEVICES
  5.1 INTRODUCTION
  5.2 DRIVERS & RESTRAINTS
      5.2.1 DEMOGRAPHIC FACTORS PROPELLING THE GROWTH
      5.2.2 NEW TECHNOLOGIES TAKING THE MARKET AHEAD
      5.2.3 HIGH DEGREE OF COMPETITION
  5.3 BURNING ISSUE
      5.3.1 ECG ON A MOVE
  5.4 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES
  5.5 CARDIAC RHYTHM MANAGEMENT DEVICES
  5.6 INTERVENTION CARDIOLOGY
  5.7 PERIPHERAL VASCULAR DEVICES
  5.8 PROSTHETIC DEVICES
  5.9 CARDIAC SURGERY DEVICES
  5.10 ELECTROPHYSIOLOGY

6 PATIENT MONITORING DEVICES
  6.1 INTRODUCTION
  6.2 DRIVERS & RESTRAINTS
      6.2.1 TECHNOLOGICAL ADVANCES FUELING THE GROWTH
      6.2.2 EMERGING MARKETS DRIVING THE GROWTH
      6.2.3 LOW COST MANUFACTURERS
  6.3 WINNING IMPERATIVE
      6.3.1 WIRELESS TECHNOLOGY DIFFERENTIATING THE PLAYERS
  6.4 PATIENT MONITORS
  6.5 VITAL SIGN MONITORS
  6.6 FETAL & NEONATAL MONITORS
  6.7 ANESTHESIA MONITORS

7 OPHTHALMOLOGY DEVICES
  7.1 INTRODUCTION
  7.2 DRIVERS
      7.2.1 INCREASING INCIDENCE OF OPHTHALMOLOGY DISEASES
      7.2.2 TECHNOLOGICAL ADVANCES DRIVING THE MARKET
  7.3 RESTRAINTS
      7.3.1 HIGH COST OF TREATMENT
      7.3.2 LACK OF REIMBURSEMENT FOR LASER PROCEDURES
  7.4 WINNING IMPERATIVES
      7.4.1 POSITIONING THE PRODUCT PROPERLY GIVES A COMPETITIVE EDGE
  7.5 CATARACT DEVICES
      7.5.1 INTRAOCULAR LENS
      7.5.2 PHACOEMULSIFICATION EQUIPMENT & VISCOELASTIC DEVICES
  7.6 REFRACTIVE ERROR
      7.6.1 CONTACT LENS
      7.6.2 EXCIMER LASER

8 MINIMALLY INVASIVE SURGICAL DEVICES,  BY SURGERY
  8.1 INTRODUCTION
  8.2 DRIVERS & RESTRAINTS
      8.2.1 MANY ADVANTAGES OF NON-INVASIVE SURGERY
      8.2.2 HIGH INITIAL COST
      8.2.3 RESTRICTED PATIENT APPLICABILITY
  8.3 TRENDS
      8.3.1 INCREASING USE OF SHAPE MEMORY ALLOY
  8.4 WINNING IMPERATIVES
      8.4.1 INNOVATION IS THE KEY TO SUCCESS
  8.5 CARDIOTHORACIC SURGERY
  8.6 ORTHOPEDIC SURGERY
  8.7 GASTROINTESTINAL SURGERY
  8.8 GYNECOLOGY SURGERY

9 KIDNEY/DIALYSIS DEVICES
  9.1 INTRODUCTION
  9.2 DRIVERS
      9.2.1 INCREASE IN THE CASES OF CHRONIC KIDNEY DISEASES
      9.2.2 LESS NUMBER OF DONORS FOR RENAL TRANSPLANTS
  9.3 RESTRAINTS
      9.3.1 LOW PENETRATION IN DEVELOPING MARKET
      9.3.2 MARKET DOMINATED BY FEW LARGE PLAYERS
  9.4 WINNING IMPERATIVE
      9.4.1 INTEGRATION HELPS IN CUTTING DOWN THE COST
  9.5 HEMODIALYSIS PRODUCTS
  9.6 PERITONEAL DIALYSIS PRODUCTS

10 POINT-OF-CARE DIAGNOSTIC DEVICES
  10.1 INTRODUCTION
  10.2 DRIVERS & RESTRAINTS
      10.2.1 SELF TESTING GIVING THE MOMENTUM
      10.2.2 MANY ADVANTAGES OF POINT-OF-CARE TESTING
      10.2.3 HIGHLY FRAGMENTED INDUSTRY
  10.3 BLOOD GLUCOSE MONITORING
  10.4 BLOOD CHEMISTRY & ELECTROLYTE
  10.5 PREGNANCY/FERTILITY
  10.6 CARDIOLOGY
  10.7 DRUG OF ABUSE MEASURING DEVICES
  10.8 INFECTIOUS DISEASES

11 ANESTHESIA & RESPIRATORY CARE DEVICES
  11.1 INTRODUCTION
  11.2 DRIVERS & RESTRAINTS
      11.2.1 TECHNOLOGY ADVANCEMENTS
      11.2.2 COMPETITIVE PRICING BY OEMS
  11.3 OPPORTUNITIES
      11.3.1 MEDICAL TOURISM
  11.4 BURNING ISSUES
      11.4.1 U.S. HEALTH REFORMS TO IMPACT THE MARKET FOR ANESTHESIA & RESPIRATORY DEVICES
      11.4.2 INFORMATION TECHNOLOGY IN RESPIRATORY & ANESTHESIA DEVICES
  11.5 ANESTHESIA DEVICES
      11.5.1 ANESTHESIA MACHINES
            11.5.1.1 Workstations
            11.5.1.2 Delivery machines
            11.5.1.3 Ventilators
            11.5.1.4 Monitors
      11.5.2 ANESTHESIA DISPOSABLES
            11.5.2.1 Endotracheal tubes
            11.5.2.2 Anesthesia gas masks
            11.5.2.3 Anesthesia breathing circuits
  11.6 RESPIRATORY CARE DEVICES
      11.6.1 DRIVERS
            11.6.1.1 High prevalence of respiratory diseases
            11.6.1.2 Changing lifestyle & increasing number of smokers
            11.6.1.3 Growing number of aged people
            11.6.1.4 Technological advancements
      11.6.2 RESTRAINTS
            11.6.2.1 Economic slowdown
      11.6.3 KEY TRENDS
            11.6.3.1 Emerging economies demand cost-efficient equipment
            11.6.3.2 More focus on compact devices for diagnostics
      11.6.4 RESPIRATORY CARE THERAPEUTICS DEVICES
            11.6.4.1 Drivers
                     11.6.4.1.1 Home healthcare growth has led to increased demand for therapeutic devices
                     11.6.4.1.2 User-friendly systems & technology increases the adoption of devices
            11.6.4.2 Restraints
                     11.6.4.2.1 Market saturation
                     11.6.4.2.2 High cost of ownership restricts the adoption of devices
            11.6.4.3 Opportunities
                     11.6.4.3.1 Used in delivery of Vaccines, Systemic Therapy & Gene-replacement Therapy
            11.6.4.4 Burning issues
                     11.6.4.4.1 Ban on chlorofluorocarbon based Propellants
                     11.6.4.4.2 Reduction in the reimbursement amount for Home Oxygen
            11.6.4.5 Winning imperatives
                     11.6.4.5.1 Lower operating costs & packaging give a long-term advantage
                     11.6.4.5.2 Portability is a key distinguishing feature
            11.6.4.6 Humidifiers
                     11.6.4.6.1 Heated Humidifiers
                     11.6.4.6.2 Passover Humidifiers
            11.6.4.7 Further classification of heated & passover humidifiers
                     11.6.4.7.1 Integrated humidifiers
                     11.6.4.7.2 Built-in humidifiers
                     11.6.4.7.3 Stand alone humidifiers
            11.6.4.8 Nebulizers
                     11.6.4.8.1 Compressor-based Nebulizers
                     11.6.4.8.2 Piston-based hand held nebulizers
                     11.6.4.8.3 Ultrasonic nebulizers
            11.6.4.9 Oxygen concentrators
                     11.6.4.9.1 Fixed oxygen concentrators
                     11.6.4.9.2 Portable oxygen concentrators
            11.6.4.10 Positive Airway Pressure (PAP) devices
                     11.6.4.10.1 Continuous Positive Airway Pressure (CPAP) devices
                     11.6.4.10.2 Other PAP devices market
                     11.6.4.11 Reusable resuscitators
            11.6.4.12 Ventilators
                     11.6.4.12.1 Adult Ventilators
                     11.6.4.12.2 Neonatal Ventilators
            11.6.4.13 Respiratory inhalers
                     11.6.4.13.1 Dry Powder Inhaler (DPI)
                     11.6.4.13.2 Metered dose inhaler
      11.6.5 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES
            11.6.5.1 Drivers & restraints
                     11.6.5.1.1 Rising importance of monitoring respiratory diseases
                     11.6.5.1.2 High level of saturation in pulse oximeter
            11.6.5.2 Burning issues
                     11.6.5.2.1 WHO initiation for developing cost effective oximeters
      11.6.5.3 Winning imperatives
                     11.6.5.3.1 Pulse oximeter market players focusing on additional features to gain competitive edge
                     11.6.5.3.2 Compactness of devices as a unique selling proposition
            11.6.5.4 Respiratory care monitoring devices
                     11.6.5.4.1 Pulse oximeter
                                11.6.5.4.1.1 Pulse oximeter equipment
                                11.6.5.4.1.2 Handheld pulse oximeters
                                11.6.5.4.1.3 Fingertip pulse oximeters
                                11.6.5.4.1.4 Tabletop pulse oximeters
                                11.6.5.4.1.5 Wrist worn pulse oximeters
                                11.6.5.4.1.6 Pulse oximeter sensors
                    11.6.5.4.2 Capnographs
                    11.6.5.4.3 Gas analyzers
            11.6.5.5 Respiratory disposables
                    11.6.5.5.1 Oxygen mask
                    11.6.5.5.2 Resuscitators
                    11.6.5.5.3 Tracheostomy tubes
                    11.6.5.5.4 Oxygen Cannulae
      11.6.6 RESPIRATORY CARE DIAGNOSTIC DEVICES (RESPIRATORY MEASUREMENT DEVICES)
            11.6.6.1 Drivers & Restraints
                    11.6.6.1.1 Developing economies emerging as fast growth markets for diagnostic technologist
                    11.6.6.1.2 Complicated Reimbursements process in diagnostic segment
                    11.6.6.1.3 Highly competitive
            11.6.6.2 Opportunities
                    11.6.6.2.1 Point-of-care diagnostics an upcoming opportunity
            11.6.6.3 Burning issues & trends
                    11.6.6.3.1 Spirometry in Toddlers/Infants a challenge
                    11.6.6.3.2 Spirometer on iphone
            11.6.6.4 Winning imperatives
                    11.6.6.4.1 Focus on accurate & clinically important information
            11.6.6.5 Spirometer
                    11.6.6.5.1 Mechanical volume spirometers
                    11.6.6.5.2 Automated flow spirometers
            11.6.6.6 Peak flow meters
            11.6.6.7 Recorders/polysomnography devices
            11.6.6.8 Other diagnostic devices
                    11.6.6.8.1 Exercise testing equipment
            11.6.6.8.2 Pneumotachometer
                    11.6.6.8.2.1 Fleisch type pneumotachometer
                    11.6.6.8.2.2 Lilly type pneumotachometer
            11.6.6.8.3 Plethysmograph

12 DIABETES CARE DEVICES
  12.1 INTRODUCTION
  12.2 DRIVERS
      12.2.1 INCREASING OBESITY
      12.2.2 DEVELOPING ECONOMIES ARE PANDEMIC CENTERS OF DIABETES
  12.3 RESTRAINTS
      12.3.1 AFFORDABILITY LIMITS THE GROWTH IN DEVELOPING COUNTRIES
      12.3.2 RIGID MIND SET OF HEALTHCARE PROVIDERS
  12.4 WINNING IMPERATIVES
      12.4.1 KEY OPINION LEADERS HOLD THE KEY
      12.4.2 DISTRIBUTION IS THE BACKBONE TO SUCCESS
  12.5 TRENDS
      12.5.1 COMBINATION OF FUNCTIONS
      12.5.2 DIABETES VACCINE & INHALABLE INSULIN
  12.6 GLUCOSE MONITORING DEVICES
      12.6.1 BLOOD GLUCOSE TEST STRIPS
      12.6.2 BLOOD GLUCOSE METERS & LANCETS
  12.7 INSULIN DELIVERY DEVICES

13 ORTHOPEDICS DEVICES
  13.1 INTRODUCTION
  13.2 DRIVERS
      13.2.1 ORTHOBIOLOGICS DRIVING THE INDUSTRY
      13.2.2 INCREASING REQUIREMENTS OF ORTHOPEDIC TRANSPLANTS
  13.3 RESTRAINTS
      13.3.1 FEW MAJOR MARKET PLAYERS
      13.3.2 ECONOMIC SLOWDOWN
  13.4 ORTHOBIOLOGICS
  13.5 JOINT RECONSTRUCTION
  13.6 SPINAL SURGERY DEVICES
  13.7 TRAUMA FIXATION PRODUCTS
  13.8 ARTHROSCOPIC DEVICES
  13.9 ORTHOPEDIC ACCESSORIES
  13.1 ORTHOPEDIC BRACES & SUPPORTS

14 GEOGRAPHIC ANALYSIS
  14.1 INTRODUCTION
  14.2 NORTH AMERICA
  14.3 EUROPE
  14.4 ASIA
  14.5 ROW

15 COMPETITIVE LANDSCAPE
  15.1 INTRODUCTION

16 COMPANY PROFILES
  16.1 3M COMPANY
      16.1.1 OVERVIEW
      16.1.2 PRODUCTS & SERVICES
      16.1.3 FINANCIALS
      16.1.4 STRATEGY
      16.1.5 DEVELOPMENTS
  16.2 ABBOTT LABORATORIES
      16.2.1 OVERVIEW
      16.2.2 PRODUCTS & SERVICES
      16.2.3 FINANCIALS
      16.2.4 STRATEGY
      16.2.5 DEVELOPMENTS
  16.3 AGFA HEALTHCARE
      16.3.1 OVERVIEW
      16.3.2 PRODUCTS & SERVICES
      16.3.3 STRATEGY
      16.3.4 DEVELOPMENTS
  16.4 ALCON
      16.4.1 OVERVIEW
      16.4.2 PRODUCTS & SERVICES
      16.4.3 FINANCIALS
      16.4.4 STRATEGY
      16.4.5 DEVELOPMENTS
  16.5 ALLERGAN INC.
      16.5.1 OVERVIEW
      16.5.2 PRODUCTS & SERVICES
      16.5.3 FINANCIALS
      16.5.4 STRATEGY
      16.5.5 DEVELOPMENTS
  16.6 B. BRAUN
      16.6.1 OVERVIEW
      16.6.2 PRODUCTS & SERVICES
      16.6.3 FINANCIALS
      16.6.4 STRATEGY
      16.6.5 DEVELOPMENTS
  16.7 BAXTER INTERNATIONAL
      16.7.1 OVERVIEW
      16.7.2 PRODUCTS & SERVICES
      16.7.3 FINANCIALS
      16.7.4 STRATEGY
      16.7.5 DEVELOPMENTS
  16.8 BECKMAN COULTER
      16.8.1 OVERVIEW
      16.8.2 PRODUCTS & SERVICES
      16.8.3 FINANCIALS
      16.8.4 STRATEGY
      16.8.5 DEVELOPMENTS
  16.9 BECTON DICKINSON
      16.9.1 OVERVIEW
      16.9.2 PRODUCTS & SERVICES
      16.9.3 FINANCIALS
      16.9.4 STRATEGY
      16.9.5 DEVELOPMENTS
  16.10 BIOMET
      16.10.1 OVERVIEW
      16.10.2 PRODUCTS & SERVICES
      16.10.3 FINANCIALS
      16.10.4 STRATEGY
      16.10.5 DEVELOPMENTS
  16.11 BOSTON SCIENTIFIC CORPORATION
      16.11.1 OVERVIEW
      16.11.2 PRODUCTS & SERVICES
      16.11.3 FINANCIALS
      16.11.4 STRATEGY
      16.11.5 DEVELOPMENTS
  16.12 C.R. BARD
      16.12.1 OVERVIEW
      16.12.2 PRODUCTS & SERVICES
      16.12.3 FINANCIALS
      16.12.4 STRATEGY
      16.12.5 DEVELOPMENTS
  16.13 CARDINAL HEALTH
      16.13.1 OVERVIEW
      16.13.2 PRODUCTS & SERVICES
      16.13.3 FINANCIALS
      16.13.4 STRATEGY
      16.13.5 DEVELOPMENTS
  16.14 COVIDIEN
      16.14.1 OVERVIEW
      16.14.2 PRODUCTS & SERVICES
      16.14.3 FINANCIALS
      16.14.4 STRATEGY
      16.14.5 DEVELOPMENTS
  16.15 DANAHER
      16.15.1 OVERVIEW
      16.15.2 PRODUCTS & SERVICES
      16.15.3 FINANCIALS
      16.15.4 STRATEGY
      16.15.5 DEVELOPMENTS
  16.16 DENTSPLY INTERNATIONAL
      16.16.1 OVERVIEW
      16.16.2 PRODUCTS & SERVICES
      16.16.3 FINANCIALS
      16.16.4 STRATEGY
      16.16.5 DEVELOPMENTS
  16.17 FRESENIUS MEDICAL CARE
      16.17.1 OVERVIEW
      16.17.2 PRODUCTS & SERVICES
      16.17.3 FINANCIALS
      16.17.4 STRATEGY
      16.17.5 DEVELOPMENTS
  16.18 GE HEALTHCARE
      16.18.1 OVERVIEW
      16.18.2 PRODUCTS & SERVICES
      16.18.3 STRATEGY
      16.18.4 DEVELOPMENTS
  16.19 HITACHI MEDICAL CORPORATION
      16.19.1 OVERVIEW
      16.19.2 PRODUCTS & SERVICES
      16.19.3 FINANCIALS
      16.19.4 STRATEGY
      16.19.5 DEVELOPMENTS
  16.20 HOSPIRA
      16.20.1 OVERVIEW
      16.20.2 PRODUCTS & SERVICES
      16.20.3 FINANCIALS
      16.20.4 STRATEGY
      16.20.5 DEVELOPMENTS
  16.21 JOHNSON & JOHNSON
      16.21.1 OVERVIEW
      16.21.2 PRODUCTS & SERVICES
      16.21.3 FINANCIALS
      16.21.4 STRATEGY
      16.21.5 DEVELOPMENTS
  16.22 MEDTRONIC INC.
      16.22.1 OVERVIEW
      16.22.2 PRODUCTS & SERVICES
      16.22.3 FINANCIALS
      16.22.4 STRATEGY
      16.22.5 DEVELOPMENTS   
  16.23 OLYMPUS CORPORATION
      16.23.1 OVERVIEW
      16.23.2 PRODUCTS & SERVICES
      16.23.3 FINANCIALS
      16.23.4 STRATEGY
  16.24 PHILIPS HEALTHCARE
      16.24.1 OVERVIEW
      16.24.2 PRODUCTS & SERVICES
      16.24.3 FINANCIALS
      16.24.4 STRATEGY
      16.24.5 DEVELOPMENTS
  16.25 SIEMENS HEALTHCARE
      16.25.1 OVERVIEW
      16.25.2 PRODUCTS & SERVICES
      16.25.3 STRATEGY
      16.25.4 DEVELOPMENTS
  16.26 SMITH & NEPHEW
      16.26.1 OVERVIEW
      16.26.2 PRODUCTS & SERVICES
      16.26.3 FINANCIALS
      16.26.4 STRATEGY
      16.26.5 DEVELOPMENTS
  16.27 ST. JUDE MEDICAL INC.
      16.27.1 OVERVIEW
      16.27.2 PRODUCTS & SERVICES
      16.27.3 FINANCIALS
      16.27.4 STRATEGY
      16.27.5 DEVELOPMENTS
  16.28 STRYKER
      16.28.1 OVERVIEW
      16.28.2 PRODUCTS & SERVICES
      16.28.3 FINANCIALS
      16.28.4 STRATEGY
      16.28.5 DEVELOPMENTS
  16.29 SYNTHES INC.
      16.29.1 OVERVIEW
      16.29.2 PRODUCTS & SERVICES
      16.29.3 FINANCIALS
      16.29.4 STRATEGY
      16.29.5 DEVELOPMENTS
  16.3 TERUMO MEDICAL CORP
      16.30.1 OVERVIEW
      16.30.2 PRODUCTS & SERVICES
      16.30.3 STRATEGY
      16.30.4 DEVELOPMENTS
  16.31 TOSHIBA
      16.31.1 OVERVIEW
      16.31.2 PRODUCTS & SERVICES
      16.31.3 FINANCIALS
      16.31.4 STRATEGY
      16.31.5 DEVELOPMENTS
  16.32 ZIMMER HOLDINGS
      16.32.1 OVERVIEW
      16.32.2 PRODUCTS & SERVICES
      16.32.3 FINANCIALS
      16.32.4 STRATEGY
      16.32.5 DEVELOPMENTS

APPENDIX 
  US PATENTS
  EUROPE PATENTS
  JAPAN PATENTS

LIST OF TABLES

TABLE 1 GLOBAL TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 2 GLOBAL DIAGNOSTIC IMAGING DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 3 DIAGNOSTIC IMAGING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 4 GLOBAL DIAGNOSTIC IMAGING DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 5 ULTRASOUND MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 6 X-RAY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 7 NUCLEAR IMAGING MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 8 MRI MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 9 COMPUTED TOMOGRAPHY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 10 GLOBAL CARDIOVASCULAR DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 11 CARDIOVASCULAR DEVICES MARKET REVENUE,  BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 12 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 13 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 14 INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 15 PERIPHERAL VASCULAR DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 16 PROSTHETIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 17 CARDIAC SURGERY DEVICES MARKET REVENUE,  BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 18 ELECTROPHYSIOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 19 GLOBAL PATIENT MONITORING DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 20 PATIENT MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 21 PATIENT MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 22 VITAL SIGN MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 23 FETAL & NEONATAL MONITORS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 24 ANESTHESIA MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 25 GLOBAL OPHTHALMOLOGY DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 26 OPHTHALMOLOGY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 27 GLOBAL CATARACT DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 28 CATARACT DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 29 INTRAOCULAR LENS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 30 PHACOEMULSIFICATION EQUIPMENT & VISCOELASTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 31 GLOBAL REFRACTIVE ERROR MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 32 REFRACTIVE ERROR MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 33 GLOBAL REFRACTIVE ERROR DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 34 CONTACT LENS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 35 EXCIMER LASER MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 36 GLOBAL MINIMALLY INVASIVE SURGICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 37 MINIMALLY INVASIVE SURGICAL DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 38 CARDIOTHORACIC SURGERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 39 ORTHOPEDIC SURGERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 40 GASTROINTESTINAL SURGERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 41 GYNECOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 42 GLOBAL DIALYSIS DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 43 DIALYSIS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 44 HEMODIALYSIS PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 45 PERITONEAL DIALYSIS PRODUCTS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 46 GLOBAL POC DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 47 POC DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 48 BLOOD GLUCOSE MONITORING MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 49 BLOOD CHEMISTRY & ELECTROLYTE MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 50 PREGNANCY/FERTILITY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 51 CARDIOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 52 DRUG OF ABUSE MEASURING DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 53 INFECTIOUS DISEASE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 54 GLOBAL ANESTHESIA & RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 55 ANESTHESIA & RESPIRATORY CARE DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 56 GLOBAL ANESTHESIA DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 57 ANESTHESIA DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 58 GLOBAL ANESTHESIA MACHINES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 59 ANESTHESIA MACHINES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 60 GLOBAL ANESTHESIA MONITORS & WORKSTATIONS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 61 ANESTHESIA WORK STATIONS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 62 ANESTHESIA DELIVERY MACHINES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 63 ANESTHESIA VENTILATORS MARKET REVENUE,  BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 64 ANESTHESIA MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 65 GLOBAL ANESTHESIA DISPOSABLES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 66 ANESTHESIA DISPOSABLES MARKET REVENUE,  BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 67 GLOBAL ANESTHESIA DISPOSABLES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 68 ENDOTRACHEAL TUBES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 69 ANESTHESIA GAS MASKS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 70 ANESTHESIA BREATHING CIRCUITS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 71 GLOBAL RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 72 RESPIRATORY CARE DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 73 GLOBAL RESPIRATORY CARE THERAPEUTICS DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 74 RESPIRATORY CARE THERAPEUTICS DEVICES MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 75 RESPIRATORY CARE THERAPEUTICS DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 76 GLOBAL HUMIDIFIERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 77 GLOBAL HUMIDIFIERS MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 78 HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 79 HEATED HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 80 PASSOVER HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 81 NEBULIZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 82 GLOBAL OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 83 GLOBAL OXYGEN CONCENTRATORS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 84 OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 85 FIXED OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 86 PORTABLE OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 87 GLOBAL PAP DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 88 PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 89 CPAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 90 OTHER PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 91 REUSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 92 GLOBAL VENTILATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 93 GLOBAL VENTILATORS MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 94 VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 95 ADULT VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 96 NEONATAL VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 97 GLOBAL RESPIRATORY INHALERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 98 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 99 RESPIRATORY INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 100 DRY POWDER INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 101 METERED DOSE INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 102 GLOBAL RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 103 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 104 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 105 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 106 RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 107 GLOBAL PULSE OXIMETRY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 108 PULSE OXIMETRY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 109 PULSE OXIMETER EQUIPMENT MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 110 PULSE OXIMETER SENSORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 111 CAPNOGRAPHS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 112 GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 113 GLOBAL RESPIRATORY DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 114 GLOBAL RESPIRATORY DISPOSABLES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 115 RESPIRATORY DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 116 DISPOSABLE OXYGEN MASK MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 117 DISPOSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 118 TRACHEOSTOMY TUBES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 119 OXYGEN CANNULAE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 120 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 121 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 122 RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 123 SPIROMETERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 124 PEAK FLOW METERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 125 POLYSOMNOGRAPHY DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 126 OTHER DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 127 GLOBAL DIABETES CARE DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 128 DIABETES CARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 129 GLOBAL GLUCOSE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 130 GLUCOSE MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 131 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 132 BLOOD GLUCOSE TEST STRIPS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 133 BLOOD GLUCOSE METERS & LANCETS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 134 INSULIN DELIVERY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 135 ORTHOPEDICS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 136 ORTHOPEDICS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 137 ORTHOBIOLOGICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 138 JOINT RECONSTRUCTION MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 139 SPINAL SURGERY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 140 TRAUMA FIXATION PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 141 ARTHROSCOPIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 142 ORTHOPEDIC ACCESSORIES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 143 ORTHOPEDIC BRACES & SUPPORTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 144 TOP 10 MEDICAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 145 NORTH AMERICA: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 146 EUROPE: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 147 ASIA: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 148 ROW: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 149 AGREEMENTS & PARTNERSHIPS/CONTRACTS/ALLIANCES
TABLE 150 MERGER, ACQUISITION & COLLABORATION
TABLE 151 PRODUCT LAUNCH/PRODUCT INTEGRATION
TABLE 152 OTHER
TABLE 153 3M COMPANY: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 154 3M COMPANY: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 155 3M COMPANY: SALES, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 156 ABBOTT LABS: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 157 ABBOTT LABS: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 158 ABBOTT LABS: SALES, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 159 ALCON: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 160 ALCON: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 161 ALCON: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 162 ALLERGAN INC.: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 163 ALLERGAN INC.: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 164 ALLERGAN INC.: MARKET REVENUE, BY REGION, 2007 – 2009 ($MILLION)
TABLE 165 B. BRAUN: REVENUE AND R&D EXPENSES, 2008 – 2009 ($MILLION)
TABLE 166 B. BRAUN: MARKET REVENUE, BY GEOGRAPHY & BUSINESS SEGMENTS, 2009 ($MILLION)
TABLE 167 BAXTER INTERNATIONAL: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 168 BAXTER INTERNATIONAL: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 169 BAXTER INTERNATIONAL: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 170 BECKMAN COULTER: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 171 BECKMAN COULTER: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 172 BECKMAN COULTER: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 173 BECTON DICKINSON: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 174 BECTON DICKINSON: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 175 BECTON DICKINSON: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 176 BIOMET: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 177 BIOMET: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 178 BIOMET: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 179 BOSTON SCIENTIFIC: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 180 BOSTON SCIENTIFIC: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 181 C.R. BARD: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 182 C.R. BARD: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 183 C.R. BARD: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 184 CARDINAL HEALTH: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 185 CARDINAL HEALTH: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 186 COVIDIEN: REVENUE AND R&D EXPENSES,  2008 – 2010 ($MILLION)
TABLE 187 COVIDIEN: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 188 COVIDIEN: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 189 DANAHER: REVENUE AND R&D EXPENSES,  2008 – 2010 ($MILLION)
TABLE 190 DANAHER: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 191 DANAHER: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 192 DENTSPLY INTERNATIONAL: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 193 DENTSPLY INTERNATIONAL: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 194 DENTSPLY INTERNATIONAL: MARKET REVENUE, BY REGION, 2007 – 2009 ($MILLION)
TABLE 195 FRESENIUS MEDICAL CARE: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 196 FRESENIUS MEDICAL CARE: MARKET REVENUE,  BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 197 FRESENIUS MEDICAL CARE: MARKET REVENUE,  BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 198 HITACHI MEDICAL CORP: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 199 HITACHI MEDICAL CORP: MARKET REVENUE,  BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 200 HITACHI MEDICAL CORP: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 201 HOSPIRA: REVENUE AND R&D EXPENSES,  2007 – 2009 ($MILLION)
TABLE 202 HOSPIRA: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 203 JOHNSON & JOHNSON: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 204 JOHNSON & JOHNSON: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 205 JOHNSON & JOHNSON: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 206 MEDTRONIC: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 207 MEDTRONIC: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 208 MEDTRONIC: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 209 OLYMPUS CORP: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 210 OLYMPUS CORP: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 211 OLYMPUS CORP: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 212 SMITH & NEPHEW: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 213 SMITH & NEPHEW: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 214 SMITH & NEPHEW: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 215 ST. JUDE MEDICAL INC.: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 216 ST. JUDE MEDICAL INC.: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 217 STRYKER: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 218 STRYKER: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 219 STRYKER: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 220 SYNTHES: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 221 SYNTHES: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 222 TOSHIBA: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 223 TOSHIBA: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 224 TOSHIBA: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 225 ZIMMER HOLDINGS: REVENUE AND R&D EXPENSES,  2008 – 2010 ($MILLION)
TABLE 226 ZIMMER HOLDINGS: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL TOP 10 MEDICAL DEVICES MARKET, BY SEGMENTS
FIGURE 2 TOP 10 MEDICAL DEVICES MARKET SEGMENTATION
FIGURE 3 MEDICAL DEVICES MARKET SHARE WITH RESPECT TO TOP 30 MARKET PLAYERS (2009)
FIGURE 4 REGIONAL DOMINANCE OF TOP PLAYERS
FIGURE 5 PENETRATION OF TOP MARKET PLAYERS IN  MEDICAL DEVICES INDUSTRY
FIGURE 6 SEGMENT STUDY FOR TOP 10 MEDICAL DEVICES MARKET
FIGURE 7 PATENTS BY SEGMENTS, 2007 – 2011
FIGURE 8 PATENTS BY MARKET PLAYERS, 2007 – 2011
FIGURE 9 GLOBAL DIAGNOSTIC IMAGING DEVICES: MARKET SHARE  OF MAJOR PLAYERS (2009)
FIGURE 10 ULTRASOUND IMAGING APPLICATIONS
FIGURE 11 ULTRASOUND IMAGING MARKET SHARE (2010)
FIGURE 12 MAMMOGRAPHY EQUIPMENT MARKET SHARE (2009)
FIGURE 13 NUCLEAR IMAGING MARKET SHARE (2009)
FIGURE 14 CARDIOVASCULAR DEVICES MARKET SHARE (2009)
FIGURE 15 INTERVENTIONAL CARDIOLOGY MARKET SHARE (2009)
FIGURE 16 ELECTROPHYSIOLOGY MARKET SHARE (2009)
FIGURE 17 CATARACT DEVICES MARKET SHARE (2009)
FIGURE 18 CONTACT LENS COMPANIES MARKET SHARE (2010)
FIGURE 19 MARKET SHARE FOR FIXED OXYGEN CONCENTRATORS
FIGURE 20 MARKET SHARE FOR PORTABLE OXYGEN CONCENTRATORS
FIGURE 21 PULSE OXIMETER MARKET SHARE (2009)
FIGURE 22 ORTHOBIOLOGICS MARKET SHARE (2009)
FIGURE 23 ARTHROSCOPIC DEVICES MARKET SHARE (2009)
FIGURE 24 KEY ORGANIZATIONAL GOALS FOCUSED THROUGH PARTNERSHIP FORMATION
FIGURE 25 MAJOR STRATEGIC FOCUS, BY MARKET PLAYERS, 2009 – 2011
FIGURE 26 MAJOR PLAYERS USING DIFFERENT STRATEGIES TO GROW, 2009 – 2011